Uterine Artery Embolization With Microspheres in Patients With Leiomyoma.

Uterine Artery Embolization With Microspheres in Patients With Leiomyoma.

To evaluate the therapeutic response to uterine artery embolization in 30 patients with leiomyoma using the microspheres Embosoft (Embosoft® - Scitech Medical).

Inclusion Criteria:

• female patients from 18 to 50 years old;
• symptomatic uterine intramural leiomyomas or multiple symptomatic leiomyomas in the presence of intramural;
• patient agrees with study procedures;
• patient signs the informed consent form.

Exclusion Criteria:

• asymptomatic women;
• isolated adenomyosis, pediculated subserous myoma, submucous leiomyoma (50% of uterine cavity diameter), intraligamentous leiomyoma;
• leiomyoma diameter higher than 10 cm;
• leiomyoma above the umbilical scar;
• endometrial neoplasia or hyperplasia or presence of any malignancy
• pregnant or breast feeding women;
• active vasculitis;
• pelvic irradiation history;
• uncontrolled coagulopathies;
• renal insufficiency;
• contrast allergy;
• concomitant use of GnRH analogues.